trending Market Intelligence /marketintelligence/en/news-insights/trending/nuokuqdbtd_dvltuktorfg2 content esgSubNav
In This List

Medivir appoints acting CEO

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Medivir appoints acting CEO

Swedish pharmaceutical company Medivir AB named Uli Hacksell acting CEO.

Hacksell is succeeding Christine Lind as the company's CEO.

According to the company, Hacksell has been a director of Medivir since May 3. He was the CEO of San Diego-based Acadia Pharmaceuticals Inc. from 2000 until 2015.

Medivir is focused on the discovery and development of cancer drugs.